"PROBARE bedriver läkemedelsforskning sedan 2008 i centrala Lund och i centrala Stockholm. Vi utför läkemedelsprövningar inom olika sjukdomstillstånd men även inom medicinsk teknisk utrustning både åt det stora internationella läkemedelsbolagen men även åt de mindre lokala."

During the past decade, ProbarE i Lund AB conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProbarE i Lund AB" #1 sponsor was "Pfizer" with 11 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Imcyse SA" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProbarE i Lund AB" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pergamum AB" with 1 trials as a collaborator and "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ProbarE i Lund AB" are "Depressive Disorder, Major" (4 trials), "Cardiovascular Disease" (2 trials), "Major Depressive Disorder" (2 trials), "Pneumococcal Disease" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "ProbarE i Lund AB" in a lesser frequency.

Most popular intervention types in "ProbarE i Lund AB" are "Drug" (23 trials), "Other" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "13vPnC" (2 trials), "20vPnC" (2 trials), "Aticaprant" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "ProbarE i Lund AB" are 28 trials for "All" genders.

Currently, there are NaN active trials in "ProbarE i Lund AB". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in ProbarE i Lund AB, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in ProbarE i Lund AB, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".